Description
What is Mounjaro weight loss injection?
Mounjaro weight loss injection contains tirzepatide, which you inject once a week with a pre-filled KwikPen. It is a prescription-only medicine (POM). Because of this, a CuraPhyx prescriber will assess whether it is suitable for you through an online consultation first.
Tirzepatide acts on two gut hormone receptors, called GIP and GLP-1. As a result, it can reduce appetite, help you feel full and slow down how quickly your stomach empties.
What Mounjaro is used for
In adults, the licence covers weight management, including weight loss and keeping weight off. You use it together with a reduced-calorie diet and more physical activity. In addition, Mounjaro has a separate licence to treat type 2 diabetes that is not well controlled.
Who it may be suitable for
For weight management, the licence covers adults who meet one of the criteria below.
- a body mass index (BMI) of 30 kg/m² or more
- a BMI of 27 to under 30 kg/m² with at least one weight-related health condition, such as high blood pressure, abnormal blood fats, sleep apnoea, heart disease, prediabetes or type 2 diabetes
However, meeting these criteria does not mean you will get a prescription. The prescriber also checks your medical history, your other medicines and whether treatment is safe for you. The licence does not cover weight management in anyone under 18.
Mounjaro on the NHS: NICE guidance
NICE (TA1026) recommends tirzepatide on the NHS for adults with a BMI of at least 35 kg/m² and at least one weight-related condition. For people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean backgrounds, the BMI threshold is usually 2.5 kg/m² lower.
NHS England is also introducing it in phases, so NHS access starts with people who have the highest clinical need. Private prescribing follows the product licence instead. Even so, a prescriber still decides whether it is right for you.
Mounjaro KwikPen strengths
Each KwikPen gives four weekly doses of one strength. The six strengths are listed below.
- 2.5mg (starting dose)
- 5mg
- 7.5mg
- 10mg
- 12.5mg
- 15mg (maximum dose)
However, needles are not included in the Mounjaro pack.
How to use Mounjaro weight loss injection
Your prescriber sets your dose and decides when it changes. The usual plan from the official leaflet is shown below.
- Start with 2.5mg once a week for 4 weeks.
- After 4 weeks, the dose usually goes up to 5mg once a week.
- If needed, the prescriber can raise it in 2.5mg steps, with at least 4 weeks on each dose.
- Usual maintenance doses are 5mg, 10mg or 15mg. The maximum is 15mg once a week.
Do not change your dose yourself. Also, tell the prescriber about any side effects before your next dose increase.
If you have lost less than 5% of your starting weight 6 months after reaching your highest tolerated dose, the prescriber will review whether to continue.
How to inject
Inject once a week at any time of day, with or without meals. The steps below come from the leaflet.
- Inject under the skin of your stomach area (abdomen) or thigh. Another person can inject into the back of your upper arm.
- Change the injection site each time. If you also use insulin, choose a different site for each.
- Read the instructions for use in the pack before your first injection.
After four doses, throw the pen away, even if some liquid is left. You can change your injection day, as long as there are at least 3 days between two doses.
If you miss a dose
If 4 days or fewer have passed, inject the missed dose as soon as you can. However, if more than 4 days have passed, skip it and inject on your usual day. Then carry on with your weekly schedule, and never take two doses to make up.
Who should not use Mounjaro
Do not use Mounjaro in the situations below.
- an allergy to tirzepatide or any of the other ingredients
- pregnancy
- if you could become pregnant and are not using contraception
Also tell the prescriber if you have had pancreatitis or have severe stomach or gut problems, such as severe gastroparesis. They need to know about diabetic eye disease and severe kidney or liver problems too.
Warnings for Mounjaro KwikPen
The leaflet and the MHRA highlight the warnings below.
- Pancreatitis: stop using it and get urgent medical help if you have severe stomach pain that does not go away. The pain may spread to your back, with or without vomiting.
- Dehydration: sickness and diarrhoea can make you lose fluids. So, drink plenty to protect your kidneys.
- Gallbladder: gallstones and an inflamed gallbladder can occur.
- Low blood sugar: the risk is higher if you also take insulin or a sulfonylurea, so the prescriber may lower those doses.
- Surgery: tell the anaesthetist before any operation or sedation, because food may stay in your stomach for longer.
- Diabetic eye disease: a fast improvement in blood sugar can briefly make it worse.
In addition, each dose contains 5.4mg benzyl alcohol, which may cause allergic reactions.
Contraception, pregnancy and breastfeeding
Do not use Mounjaro if you are pregnant. If you could become pregnant, use contraception while you use it. If you plan a pregnancy, stop it at least 1 month before, as the MHRA advises.
Mounjaro may make the contraceptive pill less effective in people who are overweight or obese. For this reason, switch to a non-oral method or add a barrier method such as condoms. Do this for 4 weeks after starting and for 4 weeks after each dose increase.
MHRA guidance says not to use these medicines while breastfeeding. So, tell the prescriber if you are breastfeeding or plan to.
Other medicines with tirzepatide injection
Tirzepatide slows how quickly your stomach empties. Because of this, it can change how some tablets are absorbed. For example, the prescriber may check you more closely if you take warfarin or digoxin. Tell them about all your medicines, including insulin or a sulfonylurea for diabetes.
Possible side effects
Most side effects are mild to moderate. They happen mainly when the dose goes up. The most common ones are listed below.
- feeling sick, diarrhoea, being sick and constipation
- stomach pain, indigestion, bloating, wind and burping
- tiredness, dizziness and hair loss
- reactions where you inject
Call 999 if you have signs of a severe allergic reaction, such as a swollen face, lips or throat, or difficulty breathing. You can also report side effects to the MHRA Yellow Card scheme. See the leaflet for the full list.
Ingredients
Each 0.6ml dose contains tirzepatide at the strength on the pen. The other ingredients are sodium phosphate dibasic heptahydrate, sodium chloride, hydrochloric acid, sodium hydroxide, glycerol, phenol, benzyl alcohol and water for injections.
Storage
Keep unused pens in a fridge at 2°C to 8°C, and do not freeze them. After first use, you can keep the pen out of the fridge at up to 30°C for up to 30 days. Then throw it away. Keep it out of the sight and reach of children.
Mounjaro weight loss injection FAQs
Do I still need to change my diet?
Yes. The licence covers its use only alongside a reduced-calorie diet and more physical activity.
Is Mounjaro the same as Wegovy?
No. Mounjaro contains tirzepatide, which acts on GIP and GLP-1 receptors. In contrast, Wegovy contains semaglutide, which acts on GLP-1 receptors only. The prescriber decides which, if either, is suitable.
Can I use the liquid left in a pen?
No. Each pen gives four doses, so throw it away after the fourth dose.
Will I get a prescription after the consultation?
Not always. The prescriber will only prescribe it if it is suitable and safe for you.
Always read the patient information leaflet before use. If you have any questions, please speak to a CuraPhyx pharmacist.
Read the Mounjaro KwikPen patient information leaflet on emc.
See the NHS page about tirzepatide.
NICE guidance TA1026 covers tirzepatide for overweight and obesity.


Reviews
There are no reviews yet.